chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had vaccine with discomfort to arm after-ward. By Saturday afternoon (6/10), LUE was warm to touch. KEFLEX started. By 6/11/17 eve. arm red, warm and painful. Went to ED for eval. Had allergic reaction to KEFELX as well.
Approximately 1 hour after shots given, baby shaky, lethargic, and apnea monitor going off. Parents took child to ER, DO Tx in ER instructed to return to clinic in AM.
Flu shot put me in the hospital; This case was reported by a consumer via interactive digital media and described the occurrence of hospitalization in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced hospitalization (serious criteria hospitalization). On an unknown date, the outcome of the hospitalization was recovered/resolved.   It was unknown if the reporter considered the hospitalization to be related to Flu vaccine.  Additional case details were reported as follows: The patient reported case for himself or herself. The age at vaccination was not reported. The patient took the flu shot last time (unspecified time) and then patient was in the hospital for long time. The follow up was not required.
Patient has described, soreness, joint pain, heart palpitation, heart arrhythmia, hypertension, minor back pain, excruciating middle back pain, fatigue, injection site rash, dizziness, runny nose and sore throat.
2 days after vaccination temp. - sore throat, cough. This lasted 2 1/2 weeks. Then on the 30th of May I awoke to a painful left knee. This got worse over the course of the day. By days end knee swollen- painful to walk on. Next morning both knees ached, they felt as if they were going to explode. Couldn't knell down, or go down stairs, moved up to hips.. This lasted about a week, then moved to hands, elbows, and feet, (knees and hips felt better). Hand and fingers swelled, I could barely bend them, constant aching. They would also feel as tough they were going to sleep. No position made any difference. Swelling has gone and tingling, numbness and pain in finger persist. Over the last week it comes and goes. 6-24 it has moved back to left knee. Only joints its missed is shoulders. As of this time it is still ongoing.
Lightheadedness and Flushness reported within 15 minutes of vaccination; subsided prior to leaving clinic with no further incident.
At her last visit April 6 she reported a six-month deterioration in ability to walk, weakness, while being treated for several infections then after the Covid 19 vaccination, her strength and balance has not returned to baseline. She now uses a walker at all times, previously used a cane, requires assistance cleaning at home, previously was independent. No clear flares prior to this.
Approximately softball sized rash developed on LUQ and with additional around left flank area approximately 2 hours after injection.  The redness/rashes went away spontaneously after another 2 hours. During that time, a little discomfort in left side of throat, but no change in lung sounds, uvula or any other respiratory concerns. Later in the day (approximately 4-6 hours), baseball sized redness presented on triceps bilaterally and splotchy redness on lumbar area (about 2-3 areas). Redness/rash is still present on both triceps the next day 22 hours after injection.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 24Sep2023 at 11:00 as dose 1, single (Batch/Lot number: unknown) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin; "Known allergies: lactose and egg intolerant" (unspecified if ongoing), notes: Known allergies: lactose and egg intolerant; "Known allergies: lactose and egg intolerant" (unspecified if ongoing), notes: Known allergies: lactose and egg intolerant. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 1), for COVID-19 immunization; Covid-19 vaccine (Dose: 2), for COVID-19 immunization; Covid-19 vaccine (Dose: 3 (Booster)), for COVID-19 immunization; Covid-19 vaccine (Dose: 4 (Booster)), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 05Oct2023, outcome "recovered", COVID-19 (medically significant) with onset 05Oct2023, outcome "recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06Oct2023) Positive, notes: for the very first time; (13Oct2023) Negative. The patient tested positive for COVID-19 for the very first time on 06Oct2023. Her symptoms started the day before. They were fairly mild but still didn't feel well and had multiple cold-like symptoms. The patient started Paxlovid that evening and finished my last dose the morning of 11Oct2023. She started feeling like 50% better within a couple days of starting and felt completely better and tested negative by 13Oct2023. Therapeutic measures were taken as a result of drug ineffective, covid-19. Paxlovid was used as COVID-19 treatment from 06Oct2023 to 11Oct2023.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
9 days after receiving vaccine, my injection site became red, swollen, firm and itchy.  The injection was never sore and showed no signs until day 9. I used Cortizone cream for the itchiness. Day 12 redness looks much better, still a little itchy.
01/14/22: Severe chest and heart pain when resting and worse with breathing, back/spine pain, shoulder blade and shoulder pain.  Medic visit, ekg OK. 01/14/22: Symptoms not subsiding, visit to ER. Chest Xray OK, standard blood panel OK. Diagnosed with Costocondritis. Giving NSAID and muscle relaxer and lidocaine patch. Symptoms wax and wane for days w/heart pals, irregular beats etc. 01/27/22 Severe pain returns especially when leaning. 01/28/22 sent for spine xray and D Dimer (stat); prescription for Tramadol in case of severe pain returning. 01/29/22 Called in AM by Dr to go to ER ASAP due to "very high" D Dimer.  ER 2nd D Dimer also positive high, Chest X-Ray ok but atelectasis noted, CT chest scan for P/E no findings. ER Dr notes "sticky" rib, and poss "inflammation" or "autoimmune" or "pleurisy" causing symptoms.  Notes unusual activity on heart monitor and gives referral to see cardiologist. Cardiologist pending for 02/14/22...
Done fine after shot; was smiling and talking, when he got to car, child stiffened up, head slumped to side and eyes rolled back in head. He was unresponsive when "carried back to clinic". He was very pale and diaphoretic, respirations shallow. He was given hr/flow treatment, legs elevated and cool cloth to forehead and he came around quickly. He was given juice to drink. He remained pale; was taken to ER by mom (ambulance called but mom took on her own). 10/16/00 per mom, child is fine with no further episodes.
Patient experienced shortness of breath and turning red. Patient was give Benadryl 50mg and Tylenol 1000mg at 4:15pm and monitored until 4:50pm.  Vitals rechecked at that time  129/68 bp, 100% O2, and 64 pulse. Symptoms were resolved after the administration of medication
Hives was reported as worsened; Hives; This is a spontaneous report from a contactable consumer or other non hcp. A 19-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose1, single for COVID-19 immunisation. The patient medical history includes allergy to Erythromycin. Concomitant medications were not reported. The patient sisters all seem to have an allergy to Erythromycin. On 16Jun2021, the patient experienced hives, Hives was reported as worsened. The consumer who is calling regarding her daughter who received her first dose of the Pfizer COVID Vaccine and is experience hives would like to inquire if the hives are due to the vaccine. Caller states she is trying to figure out if Pfizer has seen this before. She states her daughter's hives showed up a couple days later after she received the vaccine on Monday. Caller states the hives are good sized hives and merging into each. The caller states her concern is if this is a systemic thing, forbearing to an anaphylactic reaction. She states she knows her daughter probably needs to see and HCP for that. No other vaccines were administered on Same Date of the Pfizer Suspect nor within 4 weeks prior to the vaccination. The events did not require visit to emergency room nor physician office. The outcome of the events was not recovered.  Follow-up attempts are needed; Information on the lot/batch number has been requested.
Swelling in her lymph nodes in Left axilla and cervical area, general malaise.  She states she can not do her job because her arm is sore.
lt leg red, swollen & hot to touch; t99 ax; pt very irritable, crying out;
FLU LIKE SYMPTOMS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. Batch number was not reported and has been requested.  No concomitant medications were reported. On an unspecified date, the subject experienced flu like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of flu like symptoms was not reported. This report was non-serious.
pt recv vax 17OCT95 & w/in 12hrs devel a fever (100 fahrenheit),chills,& flu-like sx,characterized by aches & resp sx;
Fever Narrative:  The day after vaccine administration, employee experienced fever of 101.1 F, body aches, fatigue, and swollen glands under the chin. Max temp was 101.1 F at 6am on 12/23/2020, down to 98.8 F by 10am on 12/23/2020, after employee took ibuprofen 800mg x 3. Employee instructed to continue monitoring temperature and other symptoms, and to follow up with PCP if symptoms persist or condition worsens
Red Spots on both Hands and Fingers; Tender Spots on both Hands and Fingers; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Red Spots on both Hands and Fingers) and TENDERNESS (Tender Spots on both Hands and Fingers) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in August 2020.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced RASH MACULAR (Red Spots on both Hands and Fingers) and TENDERNESS (Tender Spots on both Hands and Fingers). At the time of the report, RASH MACULAR (Red Spots on both Hands and Fingers) and TENDERNESS (Tender Spots on both Hands and Fingers) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant medical history provided.  Treatment information not provided.
arm did hurt for a day and a half; His second shot was due today, but he cancelled the appointment; hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), REFUSAL OF VACCINATION (His second shot was due today, but he cancelled the appointment) and VACCINATION SITE PAIN (arm did hurt for a day and a half) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Hives (The patient had hives before when he has chemicals on him, when he eats shrimp.).    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced URTICARIA (hives). On 01-Mar-2021, the patient experienced REFUSAL OF VACCINATION (His second shot was due today, but he cancelled the appointment). On an unknown date, the patient experienced VACCINATION SITE PAIN (arm did hurt for a day and a half). On 01-Mar-2021, REFUSAL OF VACCINATION (His second shot was due today, but he cancelled the appointment) had resolved. At the time of the report, URTICARIA (hives) and VACCINATION SITE PAIN (arm did hurt for a day and a half) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Reportedly, the patient noticed the hives on 23-Feb-2021 and started taking diphenhydramine (Benadryl) and famotidine (Pepcid). Treatment information was not provided for the events of pain in extremity and product dose omission issue.   The outcome of the events of experienced hives, arm did hurt for a day and half were considered unknown. The outcome of the event his second shot was due today, but he cancelled the appointment was considered resolved.  This report refers to a case of refusal of vaccination (second dose) for mRNA-1273, lot # unknown  with associated AEs vaccination site pain and urticaria. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: .; Sender's Comments: This report refers to a case of refusal of vaccination (second dose) for mRNA-1273, lot # unknown  with associated AEs vaccination site pain and urticaria. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
2 days after Moderna jab, left underarm tenderness. 4 days after Moderna jab, extraordinary joint pain and swelling in left knee. Previous left knee ACL replacement in 2009 and meniscus tear surgery 2010.
Extensive bruising, from R elbow to R breast , with NO findings at the injection site.
FATIGUE X 1 DAY AFTER INJECTION, SORE ARM 2 DAYS AFTER INJECTION Narrative:
My symptoms began 06/19/2022. I had a low fever of around 100. I also had a nonproductive cough, muscle aches and general malaise. I tested positive with a home test on the morning of 06/21/2022.  I called my doctor?s office and they called in Paxlovid.  I took my first dose early afternoon of that day. My symptoms were not really bad, I had a good cough, and my fever went up to 101.3.  Within 2 days I was much better, I still had the cough. I typically have long bouts of colds; I currently just have a tickle in my throat, which I feel would last for another week with my illness history.  I have been able to do a few hikes that I lead without a lot of problems, slight shortness of breath and some achy muscles although these may just be within my normal range.
tested positive for COVID-19; A spontaneous report was received from a health care provider concerning a 61 year old, male patient who developed COVID-19.     The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.    On 05-JAN-2021, approximately 7 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 039K20A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.     On 13-JAN-2021, the patient started showing symptoms of COVID-19 after being exposed on the weekend of 09-10-JAN-2021. On 15-JAN-2021, the patient tested positive for COVID-19.  The patient is still symptomatic and has a second dose scheduled for 02-FEB-2021. Treatment information was not provided.    Action taken with mRNA-1273 in response to the event(s) was not provided/unknown.  The event(s), COVID-19, was considered recovering/resolving.     Follow up: Follow-up received on 28-JAN-2021 included HCP was given the 1st dose of the vaccine on 05Jan2021 (with 2nd dose scheduled on 02Feb2021) at a health care facility. He had it on his R deltoid. He was exposed to a Covid-19 positive case the weekend of 19-10Jan2021. He started to develop symptoms of Covid-19 on 13Jan2021 and tested positive on 15Jan2021. He is still currently symptomatic. Consent to follow up obtained.
Fever; severe body aches; sweating; nightmares; headache; fever blisters inside and outside of mouth; rapid heartbeat; foggy brain; Date of start of drug: 03Aug2021, Dose Number: 1; Date of start of drug: 03Aug2021, Dose Number: 2; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Aug2021 13:00 (Lot number: FC3180) at the age of 60 years as dose 1, single and administered in arm left, administration date 03Aug2021 (Lot number: FC3183) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL; STATIN [ATORVASTATIN CALCIUM]. The following information was reported: OVERDOSE (non-serious) with onset 03Aug2021, outcome "unknown", described as "Date of start of drug: 03Aug2021, Dose Number: 1; Date of start of drug: 03Aug2021, Dose Number: 2"; PYREXIA (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "Fever"; PAIN (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "severe body aches"; HYPERHIDROSIS (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "sweating"; NIGHTMARE (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "nightmares"; HEADACHE (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "headache"; ORAL HERPES (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "fever blisters inside and outside of mouth"; HEART RATE INCREASED (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "rapid heartbeat"; FEELING ABNORMAL (non-serious) with onset 24Aug2021 03:00, outcome "not recovered", described as "foggy brain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, pain, hyperhidrosis, nightmare, headache, oral herpes, heart rate increased, feeling abnormal.  Additional information: The patient has not tested positive for COVID-19 since and post having the vaccine.  Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.  Follow-Up (10Sep2021): Follow-up attempts are completed. No further information is expected.
Aches, Sore Throat/Ears, Slight Difficulty Breathing, Lung Congestion, Mild Fever, Hoarseness, together, for 4 days - Took Aspirin.
This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 81-year-old female patient who received SHINGRIX for prophylaxis. In August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling and stiffness shoulder. On an unknown date, the outcome of the injection site pain, injection site swelling and stiffness shoulder were recovering/resolving. It was unknown if the reporter considered the injection site pain, injection site swelling and stiffness shoulder to be related to SHINGRIX. Additional details were provided as follows: This case was reported by physician for herself. Three months before the date of reporting, on 28th or 29th August 2018, the patient received SHINGRIX in the left deltoid. The patient developed tenderness, swelling, and soreness at the injection site and these symptoms have lasted for approximately 3 months. The patient stated that approximately 2 weeks before the date of reporting, the symptoms started to get a little better. The Patient also stated that her left shoulder joint seemed a bit stiff. The physician did not consent to follow-up.
Donor noted red area at left deltoid injection site and came in to be evaluated.  2 inch area red, raised, warm to the touch.
Pt came back to clinic today to report a reaction to receiving the Pneumovax vaccine in our clinic two days prior.  Pt states receiving the vaccine in the morning and that afternoon she developed swelling at and around the injection site.  Patient described at "three red splotches on my arm."  Patient also states that she developed a headache and a fever that evening.  Pt does not know her temperature maximum as she didn't actually take her temperature but she felt warm and was sweating.  Pt states that she still has some swelling to her arm but it has greatly decreased. Pt didn't take any medications for fever or swelling.
Immediately after the injection, a swelling lump began to appear. The patient was administered a cold pack on the local injection site for a few minutes, and the reaction began to diminish. The patient was counseled and was told that if the swelling is worse or hematoma appears and gets worse to seek medical care.
received Moderna lot #025L20A at 1445. at 1503 she notified observer of nausea, dizziness, and spots in her vision. Moved to a dark quiet room and had her lay down. Per her report she has only gotten 3hrs of sleep the last two nights. Vitals stable at BP 126/88 (102), HR-65, 97%, and 36.8. Rechecked vitals throughout stay remained stable. Laid down for 15mins and then sat up. After feeling good sitting up she had water, juice and crackers. At this point she reporting feeling much better and headed home after 30mins in the first aid room and 45mins after getting the vaccine. Requested that tell staff about this prior to getting second dose.
numbness of the right side of the face and neck; numbness of the right side of the shoulder; numbness of the right side of the arm; Fatigue in all over her body; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness of the right side of the face and neck), HYPOAESTHESIA (numbness of the right side of the shoulder), HYPOAESTHESIA (numbness of the right side of the arm) and FATIGUE (Fatigue in all over her body) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 immunisation.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN for Pain management, AMOXICILLIN for Renal failure, PARACETAMOL (TYLENOL).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced HYPOAESTHESIA (numbness of the right side of the face and neck), HYPOAESTHESIA (numbness of the right side of the shoulder), HYPOAESTHESIA (numbness of the right side of the arm) and FATIGUE (Fatigue in all over her body). At the time of the report, HYPOAESTHESIA (numbness of the right side of the face and neck), HYPOAESTHESIA (numbness of the right side of the shoulder), HYPOAESTHESIA (numbness of the right side of the arm) and FATIGUE (Fatigue in all over her body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was unknown.
12hr p/vax T101.5, swelling 36-40 hr massive induration erythema;non febrile;entire arm 1/2 forearm & chest axilla resolving;